Who Supplies Erlotinib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Erlotinib exports, with 94+ registered manufacturers shipping to buyers across 55+ countries — yet a handful of companies dominate the shipments. CIPLA LIMITED holds the largest share at 15.3% (export value: $409.5K). Close behind, MSN LABORATORIES PRIVATE LIMITED (9.2%, $245.3K). ALEMBIC PHARMACEUTICALS LIMITED (4.0%, $106.9K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Erlotinib? Top Manufacturers & Their Buyers
Flow of Erlotinib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Erlotinib Supplier Network — Key Market Intelligence
The Erlotinib export market from India is led by CIPLA LIMITED, which alone commands a 15.3% share, shipping $409.5K worth of product across 4 shipments. The second-largest exporter, MSN LABORATORIES PRIVATE LIMITED, contributes $245.3K (9.2%) to the overall market. Combined, the top two suppliers alone account for 24.4% of all Erlotinib exports, indicating a relatively concentrated supply base.
Across all 94 tracked manufacturers, the total Erlotinib export value stands at $2.7M from 336 shipments. The market average shipment value is $8.0K. The single largest buyer relationship in terms of trade value is 'TO THE ORDER, receiving $330.7K worth of product.
The combined buyer network spans 13 named purchasing companies, including 'TO THE ORDER, MEDPRO PHARMACEUTICA (PTY) LTD,, MSN LABS PERU SAC CAL., MSN LABS CHILE SPA R, MSN LABS PERU SAC and 8 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1CIPLA LIMITED
CIPLA LIMITED is the first-largest Erlotinib exporter from India, with a market share of 15.3% and a total export value of $409.5K across 4 shipments. Their average shipment value of $102.4K is above the market average of $8.0K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 2 named buyers in our database. 'TO THE ORDER is the dominant customer, accounting for 80.8% of this supplier's tracked business. Top customers include:
• 'TO THE ORDER — $330.7K across 3 shipments (80.8% of this supplier's total exports)
• MEDPRO PHARMACEUTICA (PTY) LTD, — $78.8K across 1 shipments (19.2% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $102.4K is 1183% above the market average of $8.0K, consistent with large-order contracts or value-added formulations.
2MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the second-largest Erlotinib exporter from India, with a market share of 9.2% and a total export value of $245.3K across 32 shipments. Their average shipment value of $7.7K is below the market average of $8.0K, reflecting a high-volume, competitive pricing strategy.
MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $73.0K across 10 shipments (29.8% of this supplier's total exports)
• MSN LABS PERU SAC CAL. — $53.3K across 7 shipments (21.7% of this supplier's total exports)
• 'TO THE ORDER — $43.3K across 6 shipments (17.7% of this supplier's total exports)
• MSN LABS CHILE SPA R — $38.5K across 5 shipments (15.7% of this supplier's total exports)
• MSN LABS PERU SAC — $37.2K across 5 shipments (15.2% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED operates with high shipment frequency (32 shipments) at a per-shipment value of $7.7K, indicating a broad distribution network with many smaller, regular orders.
3ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the third-largest Erlotinib exporter from India, with a market share of 4.0% and a total export value of $106.9K across 9 shipments. Their average shipment value of $11.9K is above the market average of $8.0K, suggesting premium or bulk contract pricing.
ALEMBIC PHARMACEUTICALS LIMITED serves 1 named buyer in our database. J. KNIPPER & COMPANY is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• J. KNIPPER & COMPANY — $106.9K across 9 shipments (100.0% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED's per-shipment value of $11.9K is 49% above the market average of $8.0K, consistent with large-order contracts or value-added formulations.
4NATCO PHARMA LIMITED
NATCO PHARMA LIMITED is the fourth-largest Erlotinib exporter from India, with a market share of 4.0% and a total export value of $106.3K across 11 shipments. Their average shipment value of $9.7K is above the market average of $8.0K, suggesting premium or bulk contract pricing.
NATCO PHARMA LIMITED serves 3 named buyers in our database. ATLANTA MEDICARE CO.LIMITED is the dominant customer, accounting for 98.5% of this supplier's tracked business. Top customers include:
• ATLANTA MEDICARE CO.LIMITED — $104.7K across 11 shipments (98.5% of this supplier's total exports)
• EVEREST BANK LTD — $1.2K across 0 shipments (1.1% of this supplier's total exports)
• EVEREST BANK LTD — $420 across 0 shipments (0.4% of this supplier's total exports)
Key Insight: NATCO PHARMA LIMITED's per-shipment value of $9.7K is 21% above the market average of $8.0K, consistent with large-order contracts or value-added formulations.
5RELIANCE LIFE SCIENCES PRIVATE LIMITED
RELIANCE LIFE SCIENCES PRIVATE LIMITED is the fifth-largest Erlotinib exporter from India, with a market share of 3.8% and a total export value of $102.9K across 7 shipments. Their average shipment value of $14.7K is above the market average of $8.0K, suggesting premium or bulk contract pricing.
RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 4 named buyers in our database. PHARMIS SARL is the dominant customer, accounting for 60.7% of this supplier's tracked business. Top customers include:
• PHARMIS SARL — $62.5K across 4 shipments (60.7% of this supplier's total exports)
• TURGUT ILACLARI A.S. — $18.9K across 1 shipments (18.4% of this supplier's total exports)
• TURGUT ILACLARI A.S. — $18.4K across 1 shipments (17.9% of this supplier's total exports)
• BIOTENG S A — $3.1K across 0 shipments (3.0% of this supplier's total exports)
Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $14.7K is 84% above the market average of $8.0K, consistent with large-order contracts or value-added formulations.
6VEXXA LIFESCIENCES PVT. LTD.
VEXXA LIFESCIENCES PVT. LTD. is the fifth-largest Erlotinib exporter from India, with a market share of 3.6% and a total export value of $97.1K across 16 shipments. Their average shipment value of $6.1K is below the market average of $8.0K, reflecting a high-volume, competitive pricing strategy.
VEXXA LIFESCIENCES PVT. LTD. serves 3 named buyers in our database. VE PHARMA INC is the dominant customer, accounting for 70.3% of this supplier's tracked business. Top customers include:
• VE PHARMA INC — $68.2K across 11 shipments (70.3% of this supplier's total exports)
• VE PHARMA INC. — $19.3K across 3 shipments (19.9% of this supplier's total exports)
• VE PHARMA INC — $9.5K across 2 shipments (9.8% of this supplier's total exports)
Key Insight: VEXXA LIFESCIENCES PVT. LTD. operates with high shipment frequency (16 shipments) at a per-shipment value of $6.1K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Erlotinib Flows
Once Erlotinib leaves the manufacturing plants of companies like CIPLA LIMITED and MSN LABORATORIES PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $2.7M. United States absorbs the largest share at 21.0% ($562.1K), followed by Thailand (18.9%) and Philippines (12.4%).
In United States — the top destination — named importers include J. KNIPPER & COMPANY, BRECKENRIDGE PHARMACEUTICAL, INC, NOVADOZ PHARMACEUTICALS LLC. In Thailand, key buyers are ATLANTA MEDICARE CO.LTD, ATLANTA MEDICARE CO.LIMITED.
This geographic spread reflects Erlotinib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Erlotinib Go? Top Importing Countries & Their Buyers
Trade flow of Erlotinib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Erlotinib imports from India, with a total trade value of $562.1K across 10 shipments — representing a 21.0% share of all Erlotinib exports. The average shipment value of $56.2K is above the global average of $8.0K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Erlotinib importers in United States: J. KNIPPER & COMPANY is the largest buyer, accounting for 19.0% ($106.9K) of this market's total imports.
• J. KNIPPER & COMPANY — $106.9K (19.0% of United States's total)
• BRECKENRIDGE PHARMACEUTICAL, INC — $91.2K (16.2% of United States's total)
• NOVADOZ PHARMACEUTICALS LLC — $35.7K (6.4% of United States's total)
Key Insight: United States's per-shipment average of $56.2K (605% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Erlotinib imports from India.
2Thailand
Thailand ranks as the second-largest destination for Erlotinib imports from India, with a total trade value of $506.0K across 5 shipments — representing a 18.9% share of all Erlotinib exports. The average shipment value of $101.2K is above the global average of $8.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Erlotinib importers in Thailand: ATLANTA MEDICARE CO.LTD is the largest buyer, accounting for 46.6% ($235.7K) of this market's total imports.
• ATLANTA MEDICARE CO.LTD — $235.7K (46.6% of Thailand's total)
• ATLANTA MEDICARE CO.LIMITED — $104.7K (20.7% of Thailand's total)
Key Insight: Thailand's per-shipment average of $101.2K (1169% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Erlotinib imports from India.
3Philippines
Philippines ranks as the third-largest destination for Erlotinib imports from India, with a total trade value of $331.5K across 21 shipments — representing a 12.4% share of all Erlotinib exports. The average shipment value of $15.8K is above the global average of $8.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Erlotinib importers in Philippines: VE PHARMA INC. is the largest buyer, accounting for 55.9% ($185.1K) of this market's total imports.
• VE PHARMA INC. — $185.1K (55.9% of Philippines's total)
• VE PHARMA INC — $142.3K (42.9% of Philippines's total)
Key Insight: Philippines's per-shipment average of $15.8K (98% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Erlotinib imports from India.
4Saudi Arabia
Saudi Arabia ranks as the fourth-largest destination for Erlotinib imports from India, with a total trade value of $330.7K across 0 shipments — representing a 12.3% share of all Erlotinib exports. The average shipment value of $330.7K is above the global average of $8.0K, indicating high-value procurement contracts or branded formulations.
Key Insight: Saudi Arabia's per-shipment average of $330.7K (4046% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Erlotinib imports from India.
5Peru
Peru ranks as the fifth-largest destination for Erlotinib imports from India, with a total trade value of $152.0K across 5 shipments — representing a 5.7% share of all Erlotinib exports. The average shipment value of $30.4K is above the global average of $8.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Erlotinib importers in Peru: MSN LABS PERU SAC CAL. is the largest buyer, accounting for 35.1% ($53.3K) of this market's total imports.
• MSN LABS PERU SAC CAL. — $53.3K (35.1% of Peru's total)
• MSN LABS PERU SAC — $37.2K (24.5% of Peru's total)
Key Insight: Peru's per-shipment average of $30.4K (281% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Peru is a key market for Erlotinib imports from India.
People Also Ask — Erlotinib Supplier & Trade Network
Who are the top suppliers of Erlotinib from India?+
Which companies buy Erlotinib from Indian manufacturers?+
Where does Erlotinib exported from India go?+
What is the market share of the top Erlotinib supplier from India?+
What is the average shipment value for Erlotinib exports from India?+
Is Erlotinib manufactured in India and exported globally?+
Which country imports the most Erlotinib from India?+
Who are the buyers of Erlotinib in Thailand?+
How concentrated is the Erlotinib supplier market in India?+
How do I find verified buyers for Erlotinib in specific countries?+
Erlotinib Trade Network — Key Takeaways
- 1CIPLA LIMITED is India's dominant Erlotinib exporter with a 15.3% market share and $409.5K in total exports — making it the single most important sourcing entity in this market.
- 2The top 94 suppliers collectively account for 39.8% of all tracked Erlotinib exports, with a combined trade value of $2.7M.
- 3United States is the largest destination market, absorbing 21.0% of India's Erlotinib exports ($562.1K). Thailand (18.9%) and Philippines (12.4%) follow.
- 4With 336 total shipments averaging $8.0K each, the Erlotinib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include 'TO THE ORDER, MEDPRO PHARMACEUTICA (PTY) LTD,, MSN LABS PERU SAC CAL., 'TO THE ORDER — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 2 customers
6 suppliers → 55 countries
Network value: $2.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Erlotinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Erlotinib.
- 2.Flow Mapping: 94 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 336 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 55 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
336 Verified Shipments
94 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists